Reverse Transcriptase Inhibitors in HIV/AIDS Therapy edited by Gail Skowron, Richard Ogden.

Despite significant pharmacological advances, the backbone of the most highly active antiretroviral therapy regimens for controlling HIV/AIDS is still a combination of reverse transcriptase inhibitors (RTIs) first discovered in the late 1980s. In Reverse Transcriptase Inhibitors in HIV/AIDS Therapy,...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Skowron, Gail (Editor), Ogden, Richard (Editor)
Format: eBook
Language:English
Published: Totowa, NJ : Humana Press : Imprint: Humana, 2006.
Edition:1st ed. 2006.
Series:Infectious Disease
Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • Structural Studies on HIV Reverse Transcriptase Related to Drug Discovery
  • Zidovudine, Lamivudine, and Abacavir
  • Stavudine, Didanosine, and Zalcitabine
  • Emtricitabine
  • Nucleotide Analogs
  • Resistance to Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
  • Pharmacokinetics of Reverse Transcriptase Inhibitors
  • Peripheral Neuropathy Associated With Nucleoside Reverse Transcriptase Inhibitor Therapy
  • Mitochondrial Dysfunction and Nucleoside Reverse Transcriptase Inhibitor Therapy
  • Mitochondrial Toxicity and Lipodystrophy
  • Nevirapine
  • Efavirenz
  • Delavirdine
  • Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors
  • Vertical Transmission of HIV and Therapeutic Interventions
  • New Reverse Transcriptase Inhibitors in Development
  • Antiretroviral Drugs for Millions.